Background: Unexpected clinical deterioration before 34 weeks gestation is an undesired course in early-onset pre-eclampsia. To safely prolong preterm gestation, accurate and timely prediction of complications is required. Method: Women with confirmed early onset pre-eclampsia were recruited from 53 maternity units in the UK to a large prospective cohort study (PREP-946) for developmenwt of prognostic models for the overall risk of experiencing a complication using logistic regression (PREP-L), and for predicting the time to adverse maternal outcome using a survival model (PREP-S). External validation of the models were carried out in a multinational cohort (PIERS-634) and another cohort from the Netherlands (PETRA-216). Main outcome measur...
BACKGROUND: Pre-eclampsia is a leading cause of maternal and perinatal mortality and morbidity. Earl...
Background: Pre-eclampsia, a condition with raised blood pressure and proteinuria is associated with...
Objective: The internally validated fulIPIERS model predicts adverse maternal outcomes in women with...
Background: Unexpected clinical deterioration before 34 weeks gestation is an undesired course in ea...
Abstract Background Unexpected clinical deterioration before 34 weeks gestation is an undesired cour...
BACKGROUND: The prognosis of early-onset pre-eclampsia (before 34 weeks' gestation) is variable. Acc...
Background: The prognosis of early-onset pre-eclampsia (before 34 weeks’ gestation) is variable. Acc...
Background: Early-onset pre-eclampsia with raised blood pressure and protein in the urine before 34 ...
Background: The prognosis of early-onset pre-eclampsia (before 34 weeks’ gestation) is variable. Acc...
BACKGROUND: The prognosis of early-onset pre-eclampsia (before 34 weeks' gestation) is variable. Acc...
Objective: A model that can predict reliably the risk of pre-eclampsia (PE)-related pregnancy compli...
BACKGROUND: Pre-eclampsia is a leading cause of maternal and perinatal mortality and morbidity. Earl...
Objective: The internally validated fullPIERS model predicts adverse maternal outcomes in women with...
BACKGROUND: Pre-eclampsia is a leading cause of maternal and perinatal mortality and morbidity. Earl...
BACKGROUND: Pre-eclampsia is a leading cause of maternal and perinatal mortality and morbidity. Earl...
Background: Pre-eclampsia, a condition with raised blood pressure and proteinuria is associated with...
Objective: The internally validated fulIPIERS model predicts adverse maternal outcomes in women with...
Background: Unexpected clinical deterioration before 34 weeks gestation is an undesired course in ea...
Abstract Background Unexpected clinical deterioration before 34 weeks gestation is an undesired cour...
BACKGROUND: The prognosis of early-onset pre-eclampsia (before 34 weeks' gestation) is variable. Acc...
Background: The prognosis of early-onset pre-eclampsia (before 34 weeks’ gestation) is variable. Acc...
Background: Early-onset pre-eclampsia with raised blood pressure and protein in the urine before 34 ...
Background: The prognosis of early-onset pre-eclampsia (before 34 weeks’ gestation) is variable. Acc...
BACKGROUND: The prognosis of early-onset pre-eclampsia (before 34 weeks' gestation) is variable. Acc...
Objective: A model that can predict reliably the risk of pre-eclampsia (PE)-related pregnancy compli...
BACKGROUND: Pre-eclampsia is a leading cause of maternal and perinatal mortality and morbidity. Earl...
Objective: The internally validated fullPIERS model predicts adverse maternal outcomes in women with...
BACKGROUND: Pre-eclampsia is a leading cause of maternal and perinatal mortality and morbidity. Earl...
BACKGROUND: Pre-eclampsia is a leading cause of maternal and perinatal mortality and morbidity. Earl...
Background: Pre-eclampsia, a condition with raised blood pressure and proteinuria is associated with...
Objective: The internally validated fulIPIERS model predicts adverse maternal outcomes in women with...